2019
DOI: 10.1007/s00299-019-02446-6
|View full text |Cite
|
Sign up to set email alerts
|

Genetic modification in Malaysia and India: current regulatory framework and the special case of non-transformative RNAi in agriculture

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(4 citation statements)
references
References 52 publications
0
4
0
Order By: Relevance
“…Skin and respiratory irritation or damage and potential environmental contamination are some risk assessment and management aspects that need to be considered if these nanotechnologies are to be commercialized. However, the particular concerns relating to RNAi silencing activities are potential off-target silencing effects on target and non-target organisms that could be elicited with sufficient sequence similarity between dsRNA and off-target transcripts [ 75 , 76 ]. Addressing the concern of possible off-target effects is especially important to ensure public buy-in as the technology reaches the market.…”
Section: Potential Risks Safety Concerns and Limitationsmentioning
confidence: 99%
See 1 more Smart Citation
“…Skin and respiratory irritation or damage and potential environmental contamination are some risk assessment and management aspects that need to be considered if these nanotechnologies are to be commercialized. However, the particular concerns relating to RNAi silencing activities are potential off-target silencing effects on target and non-target organisms that could be elicited with sufficient sequence similarity between dsRNA and off-target transcripts [ 75 , 76 ]. Addressing the concern of possible off-target effects is especially important to ensure public buy-in as the technology reaches the market.…”
Section: Potential Risks Safety Concerns and Limitationsmentioning
confidence: 99%
“…In the USA, the risks of RNAi-based biopesticides are evaluated using chemical pesticide templates while Canada, which adopts a product-based biosafety regulation, oversees topically applied RNAi (e.g., via spraying) based on trait novelty. Australia also has taken a favorable standpoint towards regulating non-transgenic RNAi and approved the proposal to exempt topically applied dsRNAs from GMO regulations (refer to schedule 1A techniques that are not gene technology), while New Zealand ruled that dsRNA-treated eukaryotic organisms do not meet the definition of a GMO (APP203395) [ 75 , 87 ]. Such decisions have facilitated approvals for field trials of dsRNA sprays, namely “BioDirect” technology that controls bee-parasitic Varroa mites (submitted by Bayer/Monsanto) [ 88 ], and a biocontrol formulation against Colorado potato beetle, Leptinotarsa decemlineata (submitted by Syngenta) [ 89 ].…”
Section: Potential Risks Safety Concerns and Limitationsmentioning
confidence: 99%
“…Over the past decades, RNAi techniques have emerged as an eco-friendly, efficient, and reliable platform for the development of GM insecticidal plants (Mao et al 2007 ; Bachman et al 2013 ; Ni et al 2017 ; Poreddy et al 2017 ; Fu et al 2019 ; Darsan Singh et al 2019 ). These plants harbor double-stranded RNAs (dsRNAs) that can target and suppress mRNA levels through the RNAi pathway and lead to insect morbidity or mortality (Zhang et al 2017 ).…”
Section: Discussionmentioning
confidence: 99%
“…Data requirements for regulatory decision-making for biocontrol products based on externally applied dsRNA are not clear (Darsan Singh et al, 2019). Nevertheless, externally applied dsRNA products will almost certainly require assessment of the acceptability of the risks that their use poses to human and animal health and the environment.…”
Section: Introductionmentioning
confidence: 99%